AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Jan, 23, 2023
“Statistically significant improvements in lung fu... See more
Jan, 17, 2023
there could be a cure/preventative for breast cancer out there
BLRX
BioLineRx, Ltd.
20.77%
$0.61 - $0.74
Feb 7th 2023 - Mar 21st 2023
Feb, 5, 2023
I believe this company can make an impact on cancer.
Jan, 25, 2023
though many here don't agree with me, AGI-134 ... See more
SRNE
Sorrento Therapeutics Inc
-69.12%
$1.02 - $0.32
Feb 2nd 2023 - Mar 10th 2023
Feb, 22, 2023
We will continue our important work of developing ... See more
Jan, 22, 2023
With the ease of rapid, large scale Good Manufactu... See more
Jan, 23, 2023
“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !
Jan, 17, 2023
there could be a cure/preventative for breast cancer out there
Jan, 13, 2023
They have a great product treating cancer with immunotherapy, peer reviewed journal
Jan, 7, 2023
Alzheimer therapies are on the top of choices.
Jan, 6, 2023
A drug that actually helps without any major side effects .. and breakthrough therapy. .
Dec, 7, 2022
Better than chemo.
Dec, 3, 2022
$AVXL The oral Anavex 2-73 therapy met the primary and secondary endpoints of the trial, with patients receiving the therapy experiencing statistically significant improvement in cognition.
Feb, 5, 2023
I believe this company can make an impact on cancer.
Jan, 25, 2023
though many here don't agree with me, AGI-134 is promising as a combination therapy too, imo.
Jan, 4, 2023
I still see this as a promising asset, when used as a combination therapy.
Dec, 2, 2022
This is great for any cancer and absolutely ground breaking for pancreatic cancer.
Nov, 14, 2022
In mice with melanoma, AGI-134 completely eliminated tumors in more than half of the animals.
Oct, 15, 2022
$BLRX cancer vaccine news couldn’t come at a better time imo https://www.evaluate.com/node/18285/amp
Oct, 5, 2022
Injection site toxicity was mild, and no systemic toxicity or autoimmunity could be attributed to the therapy.
Oct, 5, 2022
We envisioned this study to be an enabling first step on the way to testing the clinical utility of α-Gal glycolipids in patients with solid tumors and it superseded our expectations."
Feb, 22, 2023
We will continue our important work of developing new and innovative therapies for patients struggling with cancer, intractable pain, infectious disease, and more.
Jan, 22, 2023
With the ease of rapid, large scale Good Manufacturing Practice-grade mRNA production, mRNA is ideally poised not only for off-the shelf cancer vaccines
Jan, 18, 2023
$SRNE your money is well spent , your helping research cancer & everyone here has lost a loved one https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy.html
Dec, 10, 2022
It‘s extremely distracting because this woman might have the most perfect breast I have ever seen.
Nov, 9, 2022
$SRNE $THER Ther good buy with $1 target with cancer assay news https://www.prnewswire.com/news-releases/theralink-technologies-appoints-dr-mattia-cremona-as-its-director-of-its-biopharma-laboratory-301669138.html